Furthermore, several experimental models of fibrosis suggest that IL-13 is the dominant effector in toxin, [47,48] infection, [49] allergic, [42,50] and posttransplant bronchiolitis obliterans [51] models of fibrosis. This evidence concerns the gene IL13 and infection.